Add like
Add dislike
Add to saved papers

Development of reduction scenarios for criteria air pollutants emission in Tehran Traffic Sector, Iran.

Transport-related pollution as the main source of air pollution must be reduced in Tehran mega-city. The performance of various developed scenarios including BAU (Business As Usual) as baseline scenario, ECV (Elimination of carburetor equipped Vehicle), NEM (New Energy Motorcycles), HES (Higher Emission Standard), VCR (Vehicle Catalyst Replacement), FQE (Fuel Quality Enhancement), DPF (Diesel Particulate Filter) and TSA (Total Scenarios Aggregation) are evaluated by International Vehicle Model up to 2028. In the short term, the ECV, VCR, and FQE scenarios provided high performance in CO, VOCs and NOx emissions control. Also FQE has an excellent effect on SOx emission reduction (86%) and DPF on PM emissions (20%). In the mid-term, the VCR, ECV, and FQE scenarios were presented desirable mean emission reduction on CO, VOCs, and NOx. Moreover, NOx emission reduction of DPF scenario is the most common (14%). Again FQE scenario proves to have great effect on SOx emission reduction in mid-term (86%), DPF and HES scenarios on PM (DPF: 49% and HES: 17%). Finally for the long term, VCR, ECV, FQE, and NEM scenarios were shown good performance in emission control on CO, VOCs and NOx. For SOx only FQE has a good effect in all time periods (FQE: 86%) and DPF and HES scenarios have the best effect on PM emission reduction respectively (DPF: 51% and HES: 27%) compared with BAU scenario. However, DPF scenario increases 12% SOx emission in long-term (2028). It can be generally concluded that VCR and ECV scenarios would achieve a significant reduction on gaseous pollutants emission except for SOx in general and FQE scenarios have desirable performance for all gaseous pollutants in the short term and also for SOx and VOCs in long term. In addition, the DPF and HES would be desirable scenario for emission control on PM in Tehran Traffic Sector.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app